Schwarz Phase IIb epilepsy data

Schwarz (Monheim, Germany) said in a U.S. and European double-blind, placebo-controlled Phase IIb trial in 491 patients with epilepsy, its harkoseride anticonvulsant met the primary endpoints of a red...